Healthcare Professional Blog

Education Library

 

DanGer Shock Results from Dr. Jacob Møller at ACC 2024

Jacob Møller, MD, the principal investigator of the DanGer Shock trial, discusses study results he presented at ACC 2024.

Sign Up for Latest Updates

Stay up-to-date on the latest clinical data and resources.

All Posts

Filter Results

Condition

Audience

Topic

Type

IMP-IT Subgroup analysis on revascularization extent (R-IMP IT) now published in JACC: Cardiovascular Interventions

The IMP-IT study is a national multicenter retrospective observational registry and 406 consecutive patients, treated with Impella® were …

JESFC Congress 2021: ABIOMED Symposia Recording  

Discover our symposium at E-JESFC "How to facilitate extensive revascularization in High Risk PCI using PMCS".…

EUMS Congress 2020: ABIOMED Symposia Recording Prof. Jan Bélohlavek

Discover Prof. Jan Bélohlavek's presentation on "ECMella in special conditions" at EUMS congress.

Digital Summit 2020- Cardiology: Recordings now on Demand

Discover all recordings from our first digital summit in 2020.

Subscribe for Our Healthcare Professional Newsletter

Subscribe for Our Healthcare Professional Newsletter

By subscribing you will receive our HeartRecovery newsletter for healthcare professionals with latest Impella® device news about recordings, interviews, upcoming and past events or clinical evidence.

CAMP PCI™

A Community Created by Physicians for Physicians

CAMP PCI was developed by physicians for physicians in an effort to respond to a growing crisis in coronary artery disease and heart failure.

Downloads

Discover further resources like brochures, data sheets and indications for use.

NPS-891

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].